ADAPTIVE DESIGNS AND MULTIPLE TESTING PROCEDURES WORKSHOP 2012, HEIDELBERG

Similar documents
ADAPTIVE DESIGNS AND MULTIPLE TESTING PROCEDURES WORKSHOP 2012, HEIDELBERG

Conference Website: heidelberg.de/workshop

Institute for Applied Systems Analysis (Austria) University of Vienna/Medical University of Vienna (Austria) Research/Teaching

Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls

The Role of Adaptive Designs in Clinical Development Program*

POPULATION ENRICHMENT DESIGNS FOR ADAPTIVE CLINICAL TRIALS. An Aptiv Solutions White Paper

Novel multiple testing procedures for structured study objectives and families of hypotheses a case study

Adaptive Trials. Raphaël Porcher. CRESS, Inserm UMR-S 1153, Université Paris Descartes

FDA S DRAFT GUIDANCE ON MULTIPLE ENDPOINTS IN CLINICAL TRIALS: OVERVIEW, RECEPTION AND NEXT STEPS. John Scott, Ph.D. FDA/CBER 5 October 2017

DMC membership experience. P.Bauer Basel May 2016

Adaptive Design for Clinical Trials

Adaptive Design for Medical Device Development

MRC Biostatistics Unit

PATHWAYS TO SUSTAINABLE DEVELOPMENT YOUTH IN ACTION CAMPAIGNS FOR CHANGE. Programme

Disclaimer This presentation expresses my personal views on this topic and must not be interpreted as the regulatory views or the policy of the FDA

Original papers in peer-reviewed journals

22nd Annual Meeting of GQMA

Analysis of Clinical Trials with Multiple Objectives

The Promise and Challenge of Adaptive Design in Oncology Trials

Business Offshore 2011

Draft agreed by Scientific Advice Working Party 5 September Adopted by CHMP for release for consultation 19 September

8. Clinical Trial Assessment Phase II

Quality of reporting of clinical non-inferiority and equivalence randomised trials - update and extension

Equipment and preparation required for one group (2-4 students) to complete the workshop

AFTER EMPIRE: THE LEAGUE OF NATIONS AND THE FORMER HABSBURG LANDS CALL FOR PAPERS

Enhancement of the Adaptive Signature Design (ASD) for Learning and Confirming in a Single Pivotal Trial

Wednesday October 14, Invitation only. For more information, please visit

30 th EMS Summer School

2015 Washington State Employment Law & HR Conference March 26-27, 2015 Meydenbauer Convention Center wastatecouncil.shrm.org

Guidance on Data Monitoring Committee: Regulatory Perspective in Japan

Workshop: PELLETS AND MICROPELLETS FOR ORAL MULTIPARTICULATE DOSAGE FORMS October 2017

EIP-AGRI Workshop 'New value chains from multifunctional forests' November 2016 Vienna, Austria

Timetable MONDAY, 14 MAY : Technical Session 1: Agricultural Census within the Framework of a National Survey Programme

EVENT DETAILS WHEN. Workshops 29th September

What is New on the Regulatory Front?

Fundamentals of Clinical Genomics

Some key multiplicity questions on primary and secondary endpoints of RCCTs and possible answers

Session 2 summary Designs & Methods. Pairwise comparisons approach. Dose finding approaches discussed: Guiding principles for good dose selection

Secure Interim Analysis Data Access. Management with ACES. Eric J. Silva, Cytel, Inc. Steven Ketchum, Ph.D., Sunesis Pharmaceuticals

21.European Forum on Urban Forestry conference

Reducing Food Losses & Waste: success stories, barriers, strategies for action

International Conference on Sustainable Development Goals. Severa B. De Costo, Philippine Statistics Authority

Randomized clinical trials serve as the standard for clinical

Robustness of methods for blinded sample size re-estimation with overdispersed count data

Audit Trail Review / Data Integrity

Sponsorship opportunities

Klaus Romero MD MS FCP. (Supported by the CAMD AD Modeling & Simulation Team)

Experience with Adaptive Dose-Ranging Studies in Early Clinical Development

Explore Ways to Enhance Collaboration Between Key Players

CONFERENCE VENUE LA DOUA CAMPUS, CONFERENCE BUILDINGS. Université Lyon 1 Avenue Gaston Berger. Tramway T1 Stop «La Doua Gaston BERGER»

Data and Safety Monitoring Boards

Research Xchange Forum 2018

Alternative Trial Designs

Pasteur course. 2 nd INTEGRATIVE STRUCTURAL BIOLOGY

2 nd German-Japanese Workshop on Renewable Energies 5-7 July 2017, Stuttgart, Germany

Training sites A) Institute of Veterinary Pathology, LMU Munich, Veterinärstr. 13, D Munich, DE (Sunday, Monday, Tuesday, Friday)

PDUFA VI Public Meeting Remarks of Cynthia A. Bens Alliance for Aging Research. August 15, 2016

Short Course: Adaptive Clinical Trials

Availability of Masked and De-identified Non-Summary Safety and Efficacy Data; Request for

Adaptive Clinical Trials

Bayesian modelling for combination dose-escalation trial that incorporates pharmacokinetic data

Nature Based Remediation. Workshop Program. NICOLE spring workshop 2018 Frankfurt

Agenda. Moving Jobs to the Center Stage. International Policy Workshop, November In Preparation for the World Development Report 2013

IRPA workshop on reasonableness in the implementation of the ALARA principle. Conservatoire National des Arts et Métiers (CNAM), Paris

«University Graduates Tracer Study Course 2.0 (UNITRACE 2.0)» 30/06/ /07/2016. Programme and participants list for workshop 3: «Data analysis»

Draft of Programme of the International Seminar (Russia, Moscow, October 2015)

Agile in Automotive 2016

Requirements for a GMP-compliant Data Life Cycle May 2016, Berlin, Germany. Karl-Heinz Menges Regierungspräsidium Darmstadt

Oxford Nanomedicine Summer School 29 June 3 July Nanotechnologies for Medicine and Healthcare

Productivity, Jobs, Wellbeing: Making Infrastructure Deliver

Highlights of Energy Research 2018 System Integration and Sector Coupling

SUPPORTER PROSPECTUS

WELCOME RECEPTION. Metabolomics applied to novel cardiometabolic disease mechanisms and therapeutic targets Christopher B. Newgard, Houston, USA

09/11/2015. Subject: Invitation for the 11th Global Summit of National Ethics/Bioethics Committees. Sir/Madam,

WSBI-ESBG BUSINESS FORUM

MEETING AGENDA September 2006

NEW YORK YOUTH DAIRY DISCOVERY WORKSHOP

Toronto Centre-CGAP Regional Course on Supervision of Microfinance Institutions March 2013, Kigali Hosted by Central Bank of Rwanda

Utilizing Innovative Statistical Methods. Discussion Guide

Second Quarter 2017 Financial Results. August 8, 2017

Workshop on Particle Image Velocimetry in Car Industry Towards Large Areas, TR-PIV, and Combination with Noise Measurements. Third Announcement

17th Biennial FTA State Programs Meeting and State Public Transit Partnerships Conference. Rural America On The Move

7th Conference Internal

GLASS FORMATION, STRUCTURE, AND PROPERTIES & THE TECHNOLOGY OF GLASS MELTING

Research Within Bounds

MCA Annual Conference 2017 Agenda

Nordic Alliance for Sequencing and Personalized Medicine

Clinical Pharmacology: Current Topics and Case Studies

Author's response to reviews

Understanding clinical research trials

Pre-conference Workshop Programme

SUPPLY CHAIN LOGISTICS MANAGEMENT 52 nd ANNUAL EXECUTIVE SEMINAR

Two European Conferences

felasa clasa SPONSORSHIP & EXHIBITION PROSPECTUS

IIAG CONFERENCE 2017 REFINING THINKING AND HONING SKILLS June 2017 The Grand Hotel, Brighton

Application of Proteomics and Transcriptomics in EMF Research

Subnational Parliaments in the EU Multi-level Parliamentary System: Taking Stock of the Post-Lisbon Era

Comparing The Effectiveness Of New Drugs: Should The FDA Be Asking 'Does It Work' Or 'Does It Work Better'? Sean R. Tunis, MD, MSc

Transcription:

ADAPTIVE DESIGNS AND MULTIPLE TESTING PROCEDURES WORKSHOP 2012, HEIDELBERG SCIENTIFIC PROGRAM OVERVIEW THURSDAY, JULY 5 09:00 10:30 Registration and Reception 10:30 10:45 Welcome Addresses: Prof. Dr. Joachim Kirsch (Vice Dean, Medical Faculty Heidelberg) and Prof. Dr. Meinhard Kieser (Director Institute of Medical Biometry and Informatics, Heidelberg) 10:45 12:30 Session 1: Sample Size Re-Estimation 12:30 13:30 Lunch break 13:30 15:15 Session 2: Multiple Testing (1) 15:15 15:45 Coffee break 15:45 16:45 Invited Session 16:45 17:00 Coffee break 17:00 18:45 Session 3: Seamless Phase II/III Designs and Dose-Finding 19:15 20:00 Guided Tour 20:00 Conference Dinner FRIDAY, JULY 6 08:30 10:15 Session 4: Time-to-Event Data and Confidence Intervals 10:15 10:30 Coffee break 10:30 12:15 Session 5: Multiple Testing (2) 12:15 12:30 Coffee break 12:30 14:15 Session 6: Selection of Treatments or Populations 14:15 Meeting of Working Group Adaptive Designs and Multiple Testing Procedures of IBS-DR and ROeS Page 1/5

SCIENTIFIC PROGRAM DETAILED TIME SCHEDULE THURSDAY, JULY 5 09:00 10:30 REGISTRATION AND RECEPTION 10:30 10:45 WELCOME ADDRESSES: PROF. DR. JOACHIM KIRSCH (VICE DEAN, MEDICAL FACULTY HEIDELBERG) PROF. DR. MEINHARD KIESER (DIRECTOR INSTITUTE OF MEDICAL BIOMETRY AND INFORMATICS, HEIDELBERG) 10:30 12:30 SESSION 1: SAMPLE SIZE RE-ESTIMATION CHAIR: EKKEHARD GLIMM (BASEL), THOMAS JAKI (LANCASTER) Simon Schneider (Göttingen), Heinz Schmidli (Basel): Blinded and unblinded internal pilot study designs for clinical trials with over-dispersed count data Katharina Ingel, Antje Jahn-Eimermacher (Mainz): Adaptive sample size re-estimation for recurrent event data Frank Miller (Södertälje/SWE), Tim Friede (Göttingen): Blinded continuous monitoring of the nuisance parameter in clinical trials Stefan Englert, Meinhard Kieser (Heidelberg): Evaluation of sample size adaptation rules in clinical studies aiming at an overall performance optimization Florian Klinglmüller, Franz König (Wien): Testing primary and secondary endpoints in adaptive designs with sample size reassessment for promising interim results 12:30 13:30 LUNCH BREAK 13:30 15:15 SESSION 2: MULTIPLE TESTING (1) CHAIR: WILLI MAURER (BASEL), MARTIN POSCH (LONDON) Ajit Tamhane, Dror Rom (Evanston/USA): An improved Hommel-Hochberg hybrid procedure Gerhard Hommel (Mainz): p-values are random variables are they really? Klaus Strassburger, Helmut Finner (Düsseldorf): Randomized p-values and randomized empirical distribution functions in multiple testing Kornelius Rohmeyer (Hannover), Florian Klinglmüller (Wien): gmcp an R package for graphical multiple test problems Kathrin Stucke, Meinhard Kieser (Heidelberg): Sample size calculation for three-arm non-inferiority trials with Poisson distributed count data Page 2/5

15:15 15:45 COFFEE BREAK 15:45 16:45 INVITED SESSION CHAIR: MEINHARD KIESER (HEIDELBERG) Sue-Jane Wang (Silver Spring/USA): Adaptive designed clinical trials and their associated multiplicity issues including FDA s currently thinking and perspectives Hsien-Ming James Hung (Silver Spring/USA): Statistical considerations and multiplicity issues in active control trial designs 16:45 17:00 COFFEE BREAK 17:00 18:45 SESSION 3: SEAMLESS PHASE II/III DESIGNS AND DOSE-FINDING CHAIR: STEFAN ENGLERT (HEIDELBERG), JAMES HUNG (SILVER SPRING/USA) Cornelia Ursula Kunz (Warwick), Tim Friede (Göttingen): Adaptive treatment selection in seamless phase II/III trials using short-term endpoints Lisa Hampson (Lancaster), Christopher Jennison (Bath): Optimal data combination rules in seamless phase II/III clinical trials Maximo Carreras (Basel), Georg Gutjahr (Bremen): Seamless phase II/III adaptive designs with treatment selection based on drug exposure, toxicity and response Alexandra Graf, Peter Bauer (Wien): Maximum type I error rate inflation in multiarmed clinical trials with interim sample size modifications Georg Gutjahr (Bremen), Björn Bornkamp (Basel): MCP-mod without guesstimates 19:15 20:00 GUIDED TOUR 20:00 CONFERENCE DINNER Page 3/5

FRIDAY, JULY 6 08:30 10:15 SESSION 4: TIME-TO-EVENT DATA AND CONFIDENCE INTERVALS CHAIR: WERNER BRANNATH (BREMEN), GERNOT WASSMER (KÖLN) Sandra Ligges (Münster), Gernot Wassmer (Köln): Estimation of the hazard ratio in adaptive designs with sample size readjustment Sebastian Irle, Helmut Schäfer (Marburg): Interim design modifications in time-toevent studies Rene Schmidt, Joachim Gerss (Münster): Two-stage adaptive designs with test statistics with arbitrary dependence structure based on the inverse normal method Dominic Magirr, Thomas Jaki (Lancaster): Simultaneous confidence intervals that are compatible with closed testing in adaptive designs Sylvia Schmidt, Werner Brannath (Bremen): Informative simultaneous confidence intervals 10:15 10:30 COFFEE BREAK 10:30 12:15 SESSION 5: MULTIPLE TESTING (2) CHAIR: GERHARD HOMMEL (MAINZ), AJIT TAMHANE (EVANSTON/USA) Jens Stange, Thorsten Dickhaus (Berlin): An effective number of tests Marsel Scheer (Düsseldorf): Exceedance control of the number of false rejections in multiple testing Thorsten Dickhaus, Jakob Gierl (Berlin): Simultaneous test procedures in terms of p-value copulae Eric Derobert, Julie Perez (Paris): A parametrized strategy of gatekeeping, keeping untouched the probability of having at least one significant result Geraldine Rauch, Meinhard Kieser (Heidelberg): Multiplicity adjustment for composite binary endpoints 12:15 12:30 COFFEE BREAK Page 4/5

12:30 14:15 SESSION 6: SELECTION OF TREATMENTS OR POPULATIONS CHAIR: TIM FRIEDE (GÖTTINGEN), HELMUT SCHÄFER (MARBURG) Gernot Wassmer, Silke Jürgens (Köln): Designing issues in population enrichment designs Ekkehard Glimm (Basel): Clinical trial designs with delayed selection of the primary comparison James Wason, Jack Bowden (Cambridge): Multi-stage drop-the-loser designs Jack Bowden (Cambridge), Ekkehard Glimm (Basel): Conditionally unbiased and near unbiased estimation for multi-stage drop-the-losers designs Matthew Sydes, Mahesh Parmar (London): Flexible trial design in practice. Stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multiarm multi-stage randomised controlled trial 14:15 MEETING OF WORKING GROUP ADAPTIVE DESIGNS AND MULTIPLE TESTING PROCEDURES OF IBS-DR AND ROES Page 5/5